Skip to main content

Acquiring Expertise for Improved Patient Outcomes in Immune Thrombocytopenia

Recently, i3 Health provided an educational activity that has challenged knowledge gaps experienced by clinicians pertaining to the topic of improved patient outcomes in immune thrombocytopenia (ITP).   Immune thrombocytopenia is a heterogenous disorder in which patients develop an autoimmune response to platelets that results in severe cytopenia and places them at risk for bleeding events. The lack of specific criteria makes diagnosis challenging for clinicians, and understanding the patho...

Continue reading

Improving Comprehension of Graft-Versus-Host-Disease for Enhanced Patient Outcomes

Recently, i3 Health provided an educational activity that challenged knowledge gaps experienced by clinicians regarding improved patient outcomes in graft-versus-host disease (GVHD).   Graft-versus-host disease is a common complication of allogeneic hematopoietic stem cell transplant (HSCT) and a major contributor to morbidity and mortality. Acute GVHD occurs within 100 days of transplant and typically targets the skin, gastrointestinal tract, and liver. Chronic GVHD often presents within t...

Continue reading

Practice-Changing Proficiency for the Management of Marginal Zone Lymphoma

Recently, i3 Health provided an educational activity that has challenged knowledge gaps experienced by clinicians regarding new clinical perspectives in the management of marginal zone lymphoma (MZL).   Marginal zone lymphoma comprises approximately 7% of all mature non-Hodgkin lymphomas (NHLs). According to the Leukemia and Lymphoma Society┬«, there are three subtypes: extranodal MZL, also referred to as mucosa-associated lymphatic tissue (MALT) lymphoma; splenic MZL, which originates from ...

Continue reading

Increasing Knowledge to Improve Patient Outcomes in Multiple Myeloma

Recently, i3 Health provided an educational activity that has challenged knowledge gaps experienced by clinicians regarding practice-changing strategies for improved patient outcomes in multiple myeloma.   Multiple myeloma is a B-cell neoplasm characterized by aberrant expansion of plasma cells within the bone marrow and extramedullary sites. Approximately 35,780 new cases of multiple myeloma are expected to occur in the United States this year, and around 12,540 people are likely to die of...

Continue reading

Confronting Knowledge Gaps in Rare Hematologic Malignancies

In the beginning of 2022, i3 Health and Oncology Data Advisor hosted ODACon: A Rare Hematologic Malignancies Symposium, a live, virtual symposium which provided five educational activities that challenged knowledge gaps experienced by clinicians regarding hematologic malignancies, including acute lymphoblastic leukemia (ALL), Hodgkin lymphoma (HL), mantle cell lymphoma (MCL), myelodysplastic syndromes (MDS), and Waldenstrom macroglobulinemia (WM).  According to the Leukemia and Lymphoma Soc...

Continue reading

Upgrades in Understanding Therapeutic Strategies for Graft-Versus-Host Disease

An educational enduring online activity provided by i3 Health has provided efficiency and knowledge gains encompassing the evolving landscape of therapeutic strategies for graft-versus-host disease (GVHD). Graft-versus-host disease is a complication of allogeneic hematopoietic stem cell transplant (HSCT), affecting between 40% and 60% of patients and accounting for 15% of posttransplant mortality. Acute GVHD is the second-leading cause of transplant-related mortality and typically targets the sk...

Continue reading

Breast Cancer: Genomic and Clinical Risk Predict Outcomes

Women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer can be provided prognostic information based on clinicopathological features such as tumor size, histologic grade, and the presence of axillary lymph node metastases, but these factors are not always predictive of benefit from adjuvant chemotherapy. Instead, the 21-gene recurrence score, a prognostic predictive tool independent of clinicopathological features, can predict rate of di...

Continue reading